Search

You searched for "blink"

4798 results found

Case series of toxic anterior segment syndrome

1 August 2019 | | EYE - Cataract, EYE - Refractive, EYE - General
Herein we report two cases of toxic anterior segment syndrome (TASS) following uneventful cataract surgery. Both patients presented 24 hours after their uneventful operations with painless blurred vision in the operated eye. The inflammatory reaction was controlled successfully with an...

Contemporary glaucoma therapy: spoilt for choice

1 April 2014 | | EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Glaucoma: 30 years on

30 November 2023
Back in 1993, the late and great Barry Cullen FRCS (Cavan born, Dublin trained), the first editor of Eye News, asked me to write an article about the current treatment of chronic open angle glaucoma (COAG). At the time I...

Choosing a subspecialty

1 October 2019 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
It is quite worrying how many registrars reach the final years of training without choosing a subspecialty. Sometimes this is because they love everything and cannot countenance giving any of it up, but more commonly this is due to various...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

Post-stroke visual impairment: how big is the problem, how do we identify it, what we can do about it, and why does it matter?

1 December 2022 | | EYE - General
In the UK, 100,000 new strokes occur each year, with 1.3 million stroke survivors [1]. This article will focus on post-stroke visual impairment, discussing topics of how common it is, how it can be detected, possible management options and how...

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

4 August 2021 | | EYE - Paediatrics, EYE - Vitreo-Retinal, EYE - General
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...

A message from the editors

20 March 2020
Right now you may be self-isolating, self-learning about Covid-19 and / or selflessly looking after family, friends or folk next door who need supplies, meds or general cheering up, albeit at a distance. Some of us might be redeployed, frantically...

Dr Peter Davey joins the SEE Summit

15 September 2023 | SEE Summit, Peter Davey, ABDO, NHS England
The Association of British Dispensing Opticians (ABDO) has announced another speaker for the SEE Summit, Dr Peter Davey, Chief Sustainability Officer’s Clinical Fellow 2022–2023, working with NHS England on a variety of projects including net zero eyecare.

ABDO announces dates for the ABDO Clinical Conference

15 April 2024 | optometry, optician, Dispensing, conference, events, UK, Paediatric, myopia, acute, eyecare
The Association of British Dispensing Opticians (ABDO) has announced the dates for its second clinical conference. The ABDO clinical conference will take place on Sunday 6 and Monday 7 October at the ABDO National Resource Centre, Birmingham, providing two opportunities for members to attend.

A Multidisciplinary Approach to Neovascular Glaucoma in a Patient with Waldenström’s macroglobulinemia

1 December 2013 |
An 84-year-old Caucasian male attended eye casualty with a four month history of reduced vision, a dull ache and photophobia in both eyes. He had also reported dizziness, weakness and intermittent epistaxis in the nine months prior to presentation. There...

Initiatives in macular service provision

1 December 2015 | | EYE - Vitreo-Retinal
A report from Monitor in October 2015 identifies good practices that will realise most of the potential productivity gain in elective care available to NHS hospitals. These include: stratifying patients by risk and creating low-complexity pathways for lower-risk patients (tailoring...